Medication info
Ultron Sustained Release Tablets

Ultron Sustained Release Tablets

Prescription medicationTabletOral
Ingredient · strength
Acetaminophen›325mg / 1 tabletTramadol Hydrochloride›75mg / 1 tablet
Manufacturer / importer
Exus Pharmaceutical Co., Ltd.
Appearance
Light yellow oblong sustained-release film-coated tablets
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201905269 · Approved 2019.07.24 · Insurance code 658502200

Summary

Main use
Relief of moderate to severe acute and chronic pain
Who takes it
Adults
Adult dose
Adults : The dose should be adjusted according to the patient's level of pain and response to treatment. The recommended initial dose is 1 tablet. Thereafter, allow at least 12 hours between doses and do not exceed 4 tablets per day. Do not use this medicine for longer than necessary. If long-term treatment is required because of the nature and severity of the disease, conduct regular monitoring to determine whether treatment with this medicine should continue. Nausea, vomiting, itching, constipation, dizziness, and drowsiness may occur during treatment; monitor the patient's response closely and adjust treatment as appropriate. Elderly patients : The usual adult dose should be given. However, because the elimination half-life of tramadol increased by 17% when administered orally to patients aged 75 years or older, administer this medicine at intervals of at least 12 hours. Patients with renal impairment : The safety and efficacy of this medicine have not been established in patients with renal impairment; therefore, its use is not recommended. Patients with hepatic impairment : The safety and efficacy of this medicine have not been established in patients with hepatic impairment; therefore, its use is not recommended.

Ingredients

Manufacturer
Exus Pharmaceutical Co., Ltd.

Efficacy & effects

Relief of moderate to severe acute and chronic pain

  • Moderate to severe acute pain
  • chronic pain
View approved original text

This medicine is used to relieve acute and chronic pain ranging from moderate to severe.

How to take

Adult dose

Adults : The dose should be adjusted according to the patient's level of pain and response to treatment. The recommended initial dose is 1 tablet. Thereafter, allow at least 12 hours between doses and do not exceed 4 tablets per day. Do not use this medicine for longer than necessary. If long-term treatment is required because of the nature and severity of the disease, conduct regular monitoring to determine whether treatment with this medicine should continue. Nausea, vomiting, itching, constipation, dizziness, and drowsiness may occur during treatment; monitor the patient's response closely and adjust treatment as appropriate. Elderly patients : The usual adult dose should be given. However, because the elimination half-life of tramadol increased by 17% when administered orally to patients aged 75 years or older, administer this medicine at intervals of at least 12 hours. Patients with renal impairment : The safety and efficacy of this medicine have not been established in patients with renal impairment; therefore, its use is not recommended. Patients with hepatic impairment : The safety and efficacy of this medicine have not been established in patients with hepatic impairment; therefore, its use is not recommended.

Precautions

This medication can put a strain on the liver, so individuals who regularly consume more than three drinks a day should consult a doctor or pharmacist before taking it. The components of this medication can occasionally cause serious skin reactions, so if a rash or allergic symptoms occur, discontinue use immediately. This medication can increase the risk of seizures, so patients with a history of seizures or at high risk of seizures should take it with caution, especially when taken with certain antidepressants or narcotics, as the risk may be increased. Rarely, severe allergic reactions may occur during treatment with this medication, so any symptoms such as difficulty breathing or severe rashes should be reported to medical personnel immediately. Patients with acute asthma are at risk of respiratory suppression, so this medication should only be administered under the supervision of medical staff, and considering alternative non-opioid analgesics is advisable. Taking this medication together with alcohol or central nervous system depressants may lead to severe drowsiness, respiratory suppression, or coma, so caution should be taken to avoid combinations. Patients with brain injuries or high intracranial pressure may experience worsened symptoms due to this medication's respiratory suppression, so it should be used cautiously. This medication can cause mental and physical dependence, so if used over a long period, dependence should be monitored carefully. Patients with liver dysfunction may experience liver damage due to the components of this medication, so it should only be taken after consulting a doctor, and the recommended dose should not be exceeded. This medication may be faster metabolized in patients with certain genotypes, increasing the risk of respiratory suppression, so such patients need dose adjustments and symptom monitoring. This medication is not to be administered to children under 12 or children after certain surgeries due to the risk of respiratory suppression. Elderly patients or those at risk of hyponatremia should carefully monitor for symptoms of hyponatremia while taking this medication. This medication should not be given to patients with hypersensitivity, central nervous system drug addiction, severe respiratory suppression, head injuries, those on certain medications, severe hepatic, renal, or cardiac dysfunction, nursing mothers, or children. Taking this medication can cause various side effects such as drowsiness, dizziness, nausea, constipation, hives, rashes, etc., so if symptoms are severe or persistent, consult medical personnel. Caution is advised when engaging in activities requiring focus, such as driving or operating machinery, as drowsiness or dizziness may occur after taking this medication. Severe respiratory suppression and liver damage can occur in case of overdose, so it's essential to follow the dosage and administration guidelines, and in case of overdose, contact medical institutions immediately for appropriate treatment. Taking this medication in combination with other analgesics or other medications containing acetaminophen should be avoided, and possible drug interactions should be informed to medical personnel during the treatment.

Side effects

Liver damage, acute generalized exanthematous pustulosis, Stevens-Johnson syndrome, toxic epidermal necrolysis, seizures, anaphylactic reactions, respiratory depression, deep sedation, coma, weakness, fatigue, flushing, chest pain, rigidity, syncope, withdrawal symptoms, hypertension, exacerbation of hypertension, hypotension, arrhythmia, palpitations, tachycardia, dizziness, headache, tremors, ataxia, convulsions, hypertonia, migraines, exacerbation of migraines, involuntary muscle contractions, paresthesia, confusion, dizziness, abdominal pain, constipation, diarrhea, indigestion, flatulence, dry mouth, nausea, vomiting, dysphagia, hematochezia, tongue swelling, appetite loss, anxiety, confusion, intoxication, insomnia, nervousness, drowsiness, forgetfulness, depersonalization, depression, drug abuse, dependence, emotional instability, hallucinations, erectile dysfunction, nightmares, abnormal thoughts, anemia, dyspnea, proteinuria, urinary dysfunction, oliguria, urinary retention, pruritus, rash, sweating, urticaria, abnormal liver function, weight loss, tinnitus, abnormal vision, chills, vasodilation, orthostatic hypotension, bradycardia, collapse, myocardial ischemia, pulmonary edema, bronchospasm, wheezing, angioedema, allergic reactions, anaphylaxis, Stevens-Johnson syndrome, changes in appetite, muscular weakness, respiratory depression, cognitive dysfunction, difficulty concentrating, suicidal tendencies, hepatitis, liver failure, gastrointestinal bleeding, delirium, miosis, mydriasis, speech disorders, movement disorders, hypoglycemia, hyponatremia, syndrome of inappropriate antidiuretic hormone secretion, thrombocytopenia, agranulocytosis, hypoprothrombinemia, high anion gap metabolic acidosis, nausea, urticaria, headache, cold sweats, decreased appetite, dizziness, drowsiness, thirst, dry mouth, sweating, urinary dysfunction, abdominal pain, insomnia, fever, peripheral edema, weakness, pallor, blood pressure fluctuations, cough, rhinorrhea, hematuria, blood pressure increase, palpitations, irregular menstruation, breast cancer, injury, weakness, fever, edema, chest pain, rigidity, syncope, congestive heart failure, dizziness, confusion, asthma, exertional dyspnea, bronchitis, urinary retention, frequent urination, abnormal kidney function indicators, decreased hemoglobin, decreased red blood cells, decreased white blood cells, increased white blood cells, decreased platelets, palpitations, aortic stenosis, hemorrhage, elevated cholesterol, hip pain, thigh pain, allergic rhinitis, epistaxis, progression of bile duct cancer, foreign body sensation in the eye, progression of liver cancer, paralytic ileus, hiccups, cholecystitis, abnormal kidney function indicators, increased salivation, discomfort in the chest, memory impairment, lack of efficacy, facial flushing, back pain, musculoskeletal pain, neck pain, flank pain, upper respiratory infection, pneumonia, disorientation, facial flushing, withdrawal symptoms, panic attacks, severe anxiety, hallucinations, paresthesia, tinnitus, abnormal central nervous system response, urticaria, bronchospasm, toxic skin necrosis, anaphylaxis, convulsions, serotonin syndrome, withdrawal symptoms, hepatitis, liver failure, gastrointestinal bleeding, hypoglycemia, hyponatremia, syndrome of inappropriate antidiuretic hormone secretion, anemia, dyspnea, asthma, exertional dyspnea, bronchitis, hematuria, urinary dysfunction, urinary incontinence, oliguria, dry mouth, diarrhea, dysphagia, flatulence, tongue swelling, increased salivation, progression of rectal cancer, progression of esophageal cancer, progression of stomach cancer, drowsiness, insomnia, appetite loss, anxiety, depression, nervousness, emotional instability, hallucinations, depersonalization, recurrence of myocardial infarction, hypotension, multiple organ failure, intentional overdose, confusion, speech disorders, loss of consciousness, vomiting, dyspepsia, confusion, anaphylaxis, belching, chest burning, acute gastritis, cold, systemic weakness, motion sickness, transient ischemic attack, lethargy, hemorrhage, cholecystitis, paralytic ileus, abnormal kidney function indicators, increased salivation

Not everyone experiences these, and they can vary from person to person.

Storage

This medication must be stored in a tightly sealed container to prevent exposure to air or moisture. It is important to maintain a storage temperature between 1 to 30 degrees Celsius.

Appearance and packaging

Appearance

Light yellow oblong sustained-release film-coated tablets

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.